W. Unaids, Available: http:// www.unaids.org/en/HIV_data, Report on the global AIDS epidemic, 2006.

W. Moss, C. Clements, and N. Halsey, Immunization of children at risk of infection with human immunodeficiency virus, Bull World Health Organ, vol.81, pp.61-70, 2003.

C. Pancharoen, J. Ananworanich, and U. Thisyakorn, Immunization for Persons Infected with Human Immunodeficiency Virus, Current HIV Research, vol.2, issue.4, pp.293-299, 2004.
DOI : 10.2174/1570162043351084

F. Rouet, D. Ekouevi, M. Chaix, M. Burgard, and A. Inwoley, Transfer and Evaluation of an Automated, Low-Cost Real-Time Reverse Transcription-PCR Test for Diagnosis and Monitoring of Human Immunodeficiency Virus Type 1 Infection in a West African Resource-Limited Setting, Journal of Clinical Microbiology, vol.43, issue.6, pp.2709-2717, 2005.
DOI : 10.1128/JCM.43.6.2709-2717.2005

S. Scott, P. Cumberland, C. Shulman, S. Cousens, and B. Cohen, Neonatal Measles Immunity in Rural Kenya: The Influence of HIV and Placental Malaria Infections on Placental Transfer of Antibodies and Levels of Antibody in Maternal and Cord Serum Samples, The Journal of Infectious Diseases, vol.191, issue.11, pp.1854-1860, 2005.
DOI : 10.1086/429963

B. Cohen, R. Parry, D. Doblas, D. Samuel, and L. Warrener, Measles immunity testing: Comparison of two measles IgG ELISAs with plaque reduction neutralisation assay, Journal of Virological Methods, vol.131, issue.2, pp.209-212, 2006.
DOI : 10.1016/j.jviromet.2005.08.001

E. Relyveld, N. Oato, N. Guerin, P. Coursaget, and M. Huet, Determination of circulating antibodies directed to pertussis toxin and of agglutinogens in children vaccinated with either the whole cell or component pertussis vaccine in France, Japan and Senegal, Vaccine, vol.9, issue.11, pp.843-850, 1991.
DOI : 10.1016/0264-410X(91)90224-T

D. Dunn and H. Paediatric, Prognostic Markers Collaborative Study Group (2003) Short-term risk of disease progression in HIV-1-infected children receiving no antiretroviral therapy or zidovudine monotherapy: a meta-analysis, Lancet, vol.362, pp.1605-1611

M. De-onis, R. Yip, and Z. Mei, The development of MUAC-for-age reference data recommended by a WHO Expert Committee, Bull World Health Organ, vol.75, pp.11-18, 1997.

R. Setse, F. Cutts, M. Monze, J. Ryon, and T. Quinn, HIV-1 Infection as a Risk Factor for Incomplete Childhood Immunization in Zambia, Journal of Tropical Pediatrics, vol.52, issue.5, pp.324-328, 2006.
DOI : 10.1093/tropej/fmk002

R. Helfand, W. Moss, R. Harpaz, S. Scott, and F. Cutts, Evaluating the impact of the HIV pandemic on measles control and elimination, Bull World Health Organ, vol.83, pp.329-337, 2005.

L. Wolfson, P. Strebel, M. Gacic-dobo, E. Hoekstra, and J. Mcfarland, Has the 2005 measles mortality reduction goal been achieved? A natural history modelling study, The Lancet, vol.369, issue.9557, pp.191-200, 2007.
DOI : 10.1016/S0140-6736(07)60107-X

B. Rudy, R. Rutstein, and J. Pinto-martin, Responses to measles immunization in children infected with human immunodeficiency virus, The Journal of Pediatrics, vol.125, issue.1, pp.72-74, 1994.
DOI : 10.1016/S0022-3476(94)70125-3

S. Arpadi, L. Markowitz, A. Baughman, K. Shah, and H. Adam, Measles antibody in vaccinated human immunodeficiency virus type 1-infected children, Pediatrics, vol.97, pp.653-657, 1996.

C. Lindgren-alves, L. Freire, R. Oliveira, H. Guerra, and E. Da-silva, Search of antimeasles antibodies in HIV-infected children after basic immunization, Jornal de Pediatria, vol.77, issue.6, pp.496-502, 2001.
DOI : 10.2223/JPED.360

P. Lepage, F. Dabis, P. Msellati, D. Hitimana, and A. Stevens, Safety and Immunogenicity of High-Dose Edmonston-Zagreb Measles Vaccine in Children With HIV-1 Infection, American Journal of Diseases of Children, vol.146, issue.5, pp.550-555, 1992.
DOI : 10.1001/archpedi.1992.02160170030011

M. Garenne, O. Leroy, J. Beau, and I. Sene, Child mortality after high-titre measles vaccines: prospective study in Senegal, The Lancet, vol.338, issue.8772, pp.903-907, 1991.
DOI : 10.1016/0140-6736(91)91771-L

P. Waibale, S. Bowlin, E. Mortimer, . Jr, and C. Whalen, The effect of human immunodeficiency virus-1 infection and stunting on measles immunoglobulin-G levels in children vaccinated against measles in Uganda, International Journal of Epidemiology, vol.28, issue.2, pp.341-346, 1999.
DOI : 10.1093/ije/28.2.341

R. Grais, C. Dubray, S. Gerstl, J. Guthmann, and A. Djibo, Unacceptably High Mortality Related to Measles Epidemics in Niger, Nigeria, and Chad, medicine.plosjournals.org via the Internet. Accessed 17, 2007.
DOI : 10.1371/journal.pmed.0040016.sd002

W. Moss, Measles Still Has a Devastating Impact in Unvaccinated Populations, PLoS Medicine, vol.366, issue.1, p.24, 2007.
DOI : 10.1371/journal.pmed.0040024.g001

N. Bautista-lopez, B. Ward, E. Mills, D. Mccormick, and N. Martel, Development and durability of measles antigen-specific lymphoproliferative response after MMR vaccination, Vaccine, vol.18, issue.14, pp.1393-1401, 2000.
DOI : 10.1016/S0264-410X(99)00396-5

H. Gans, L. Yasukawa, M. Rinki, R. Dehovitz, and B. Forghani, Immune Responses to Measles and Mumps Vaccination of Infants at 6, 9, and 12 Months, The Journal of Infectious Diseases, vol.184, issue.7, pp.817-826, 2001.
DOI : 10.1086/323346

D. Naniche, M. Garenne, R. C. Manchester, M. Buchta, and R. , Decrease in Measles Virus???Specific CD4 T Cell Memory in Vaccinated Subjects, The Journal of Infectious Diseases, vol.190, issue.8, pp.1387-1395, 2004.
DOI : 10.1086/424571

I. Al-attar, J. Reisman, M. Muehlmann, and K. Mcintosh, Decline of measles antibody titers after immunization in human immunodeficiency virus-infected children, Pediatr Infect Dis J, vol.14, pp.149-151, 1995.

P. Brunell, V. Vimal, M. Sandu, T. Courville, and E. Daar, Abnormalities of Measles Antibody Response in Human Immunodeficiency Virus Type 1 (HIV-1) Infection, Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology, vol.10, issue.5, pp.540-548, 1995.
DOI : 10.1097/00042560-199510050-00007

V. Bekker, H. Scherpbier, D. Pajkrt, S. Jurriaans, and H. Zaaijer, Persistent Humoral Immune Defect in Highly Active Antiretroviral Therapy-Treated Children With HIV-1 Infection: Loss of Specific Antibodies Against Attenuated Vaccine Strains and Natural Viral Infection, PEDIATRICS, vol.118, issue.2, pp.315-322, 2006.
DOI : 10.1542/peds.2005-2616

M. Newell, H. Coovadia, M. Cortina-borja, N. Rollins, and P. Gaillard, Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis, The Lancet, vol.364, issue.9441, pp.1236-1243, 2004.
DOI : 10.1016/S0140-6736(04)17140-7

Z. Grossman, M. Meier-schellersheim, W. Paul, and L. Picker, Pathogenesis of HIV infection: what the virus spares is as important as what it destroys, Nature Medicine, vol.168, issue.3, pp.289-295, 2006.
DOI : 10.1038/nm1380

J. Brenchley, D. Price, and D. Douek, HIV disease: fallout from a mucosal catastrophe?, Nature Immunology, vol.438, issue.3, pp.235-239, 2006.
DOI : 10.1038/ni1316

P. Lepage, P. Msellati, D. Hitimana, A. Bazubagira, and C. Van-goethem, Growth of human immunodeficiency type 1-infected and uninfected children: a prospective cohort study in Kigali, Rwanda, 1988 to 1993, The Pediatric Infectious Disease Journal, vol.15, issue.6, pp.479-485, 1988.
DOI : 10.1097/00006454-199606000-00003

T. Taha, S. Graham, N. Kumwenda, R. Broadhead, and D. Hoover, Morbidity Among Human Immunodeficiency Virus-1-Infected and -Uninfected African Children, PEDIATRICS, vol.106, issue.6, p.77, 2000.
DOI : 10.1542/peds.106.6.e77

L. Mcnally, P. Jeena, K. Gajee, S. Thula, and A. Sturm, Effect of age, polymicrobial disease, and maternal HIV status on treatment response and cause of severe pneumonia in South African children: a prospective descriptive study, The Lancet, vol.369, issue.9571, pp.1440-1451, 2007.
DOI : 10.1016/S0140-6736(07)60670-9

M. Clerici, M. Saresella, F. Colombo, S. Fossati, and N. Sala, T-lymphocyte maturation abnormalities in uninfected newborns and children with vertical exposure to HIV, Blood, vol.96, pp.3866-3871, 2000.

A. Vigano, M. Saresella, M. Schenal, P. Erba, and L. Piacentini, Immune activation and normal levels of endogenous antivirals are seen in healthy adolescents born of HIV-infected mothers, AIDS, vol.21, issue.2, pp.245-248, 2007.
DOI : 10.1097/QAD.0b013e328011d7d3

M. Barbi, M. Biffi, S. Binda, M. Clerici-schoeller, and G. Ferraris, Immunization in children with HIV seropositivity at birth, AIDS, vol.6, issue.12, pp.1465-1469, 1992.
DOI : 10.1097/00002030-199212000-00007

R. Ryder, M. Oxtoby, M. Mvula, V. Batter, and E. Baende, Safety and immunogenicity of bacille Calmette-Gu??rin, diphtheria-tetanuspertussis, and oral polio vaccines in newborn children in Zaire infected with human immunodeficiency virus type 1, The Journal of Pediatrics, vol.122, issue.5, pp.697-702, 1993.
DOI : 10.1016/S0022-3476(06)80007-7

R. Sutter, A. Suleiman, P. Malankar, S. Al-khusaiby, and F. Mehta, Trial of a Supplemental Dose of Four Poliovirus Vaccines, New England Journal of Medicine, vol.343, issue.11, pp.767-773, 2000.
DOI : 10.1056/NEJM200009143431103

H. Triki, M. Abdallah, B. Aissa, R. Bouratbine, A. et al., Influence of host related factors on the antibody response to trivalent oral polio vaccine in Tunisian infants, Vaccine, vol.15, issue.10, pp.1123-1129, 1997.
DOI : 10.1016/S0264-410X(97)00001-7

P. Fassinou, N. Elenga, F. Rouet, R. Laguide, and K. Kouakoussui, Highly active antiretroviral therapies among HIV-1-infected children in Abidjan, C??te d'Ivoire, AIDS, vol.18, issue.14, pp.1905-1913, 2004.
DOI : 10.1097/00002030-200409240-00006

A. Faye, L. Chenadec, J. Dollfus, C. Thuret, I. Douard et al., Early versus Deferred Antiretroviral Multidrug Therapy in Infants Infected with HIV Type 1, Clinical Infectious Diseases, vol.39, issue.11, pp.1692-1698, 2004.
DOI : 10.1086/425739

E. Chiappini, L. Galli, P. Tovo, C. Gabiano, and G. Gattinara, Virologic, immunologic, and clinical benefits from early combined antiretroviral therapy in infants with perinatal HIV-1 infection., AIDS, vol.20, issue.2, pp.207-215, 2006.
DOI : 10.1097/01.aids.0000200529.64113.3e